BioCryst to Present at Upcoming Investor Conference
BioCryst (Nasdaq:BCRX) will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 12:00 p.m. ET.
The event will be available via a live audio webcast with a replay. Investors can access the live audio and replay in the Investors & Media section at www.biocryst.com.
BioCryst (Nasdaq:BCRX) presenterà al Jefferies Global Healthcare Conference a Londra il mercoledì 19 novembre 2025 alle 12:00 ora ET.
L'evento sarà disponibile tramite una webcast audio in diretta con replay. Gli investitori potranno accedere all'audio in diretta e al replay nella sezione Investors & Media sul sito www.biocryst.com.
BioCryst (Nasdaq:BCRX) participará en la Conferencia Global de Salud de Jefferies en Londres el miércoles 19 de noviembre de 2025 a las 12:00 p.m. hora ET.
El evento estará disponible a través de una transmisión de audio en vivo con una repetición. Los inversores pueden acceder al audio en vivo y a la repetición en la sección Inversores y Medios en www.biocryst.com.
BioCryst (Nasdaq:BCRX)은 런던에서 열리는 제퍼리스 글로벌 헬스케어 컨퍼런스에 2025년 11월 19일 수요일 동부 표준시 기준 정오 12:00에 발표할 예정입니다.
해당 행사는 실시간 오디오 웹캐스트와 재생을 통해 제공될 예정입니다. 투자자들은 Investors & Media 섹션의 www.biocryst.com에서 라이브 오디오와 재생에 접속할 수 있습니다.
BioCryst (Nasdaq:BCRX) sera présent lors de la Conférence mondiale sur les soins de santé de Jefferies à Londres le mercredi 19 novembre 2025 à 12h00 HE.
L'événement sera disponible via une diffusion audio en direct avec une rediffusion. Les investisseurs peuvent accéder à l'audio en direct et à la rediffusion dans la rubrique Investisseurs & Médias sur le site www.biocryst.com.
BioCryst (Nasdaq:BCRX) wird auf der Jefferies Global Healthcare Conference in London am Mittwoch, dem 19. November 2025 um 12:00 Uhr ET auftreten.
Die Veranstaltung wird über einen Live-Audio-Webcast mit einer Wiederholung verfügbar sein. Investoren können den Live-Audio und die Wiederholung im Bereich Investors & Media unter www.biocryst.com aufrufen.
BioCryst (Nasdaq:BCRX) ستقدّم في مؤتمر Jefferies العالمي للرعاية الصحية في لندن يوم الأربعاء 19 نوفمبر 2025 الساعة 12:00 ظهرًا بتوقيت شرق الولايات المتحدة.
سيكون الحدث متاحًا عبر بث صوتي مباشر مع إعادة تشغيل. يمكن للمستثمرين الوصول إلى الصوت المباشر وإعادة التشغيل في قسم المستثمرون ووسائل الإعلام على www.biocryst.com.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 12:00 p.m. ET.
The link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:
Investors:
investorrelations@biocryst.com
Media:
media@biocryst.com
FAQ
When will BioCryst (BCRX) present at the Jefferies Global Healthcare Conference?
How can investors access the BioCryst (BCRX) presentation on November 19, 2025?
Will there be a replay of the BioCryst (BCRX) Jefferies presentation?
What format is the BioCryst (BCRX) presentation at the Jefferies conference?
Where on BioCryst's website will the November 19, 2025 presentation be posted?
